GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...

to individuals diagnosed with Parkinson’s Disease or Parkinsonism. YMCA360 offers a vast library of more than 6,000 on-demand videos, which participants can access from any internet-enabled device ...

Negative drug results cost AbbVie billions of dollars in market value and convinced analysts that Bristol Myers had placed a ...

Shares in AbbVie slumped Monday after the company disclosed its psychiatric medicine emraclidine didn’t best placebo in two ...

AbbVie faces setback as schizophrenia trial for emraclidine fails, but still has potential with other assets from Cerevel.

AbbVie shares, which hit a 52-week high in late October after the drugmaker posted quarterly earnings that topped Wall Street's expectations and raised its dividend by nearly 6%, were recently down ...

Favre spoke at Trump’s rally last week in Green Bay, Wis. The post What Donald Trump’s Win Means for Welfare Probe, Brett Favre appeared first on Front Office Sports.

Donald Trump will be campaigning in Green Bay, Wisconsin, with retired NFL quarterback Brett Favre. Favre is now shadowed by ...

Favre, now 55 and recently diagnosed with Parkinson’s disease, was effective in his Trump rally debut. He took aim at ...

Although football players were an initial target market, the product is catching on with lacrosse and hockey players, as well ...

Brett Favre is caught up in a welfare scandal in his home state of Mississippi, where Auditor Shad White says he still owes the state nearly $730,000 in interest.